- Home
- SLNO vs ZGN Comparison
SLNO vs ZGN Comparison
Compare SLNO & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | ZGN |
|---|---|---|
| Founded | 1999 | 1910 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLNO | ZGN |
|---|---|---|
| Price | $31.38 | $10.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $105.27 | $11.28 |
| AVG Volume (30 Days) | ★ 1.4M | 697.1K |
| Earning Date | 05-06-2026 | 03-20-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ 108.90 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,450,788.00 | N/A |
| Revenue This Year | $150.65 | $5.12 |
| Revenue Next Year | $56.10 | $7.44 |
| P/E Ratio | $84.82 | ★ $25.94 |
| Revenue Growth | ★ 138.82 | N/A |
| 52 Week Low | $32.15 | $6.13 |
| 52 Week High | $89.12 | $11.93 |
Technical Indicators
Market Signals| Indicator | SLNO | ZGN |
|---|---|---|
| Relative Strength Index (RSI) | 29.14 | 48.62 |
| Support Level | N/A | $10.16 |
| Resistance Level | $41.48 | $10.73 |
| Average True Range (ATR) | 1.83 | 0.41 |
| MACD | -0.49 | -0.06 |
| Stochastic Oscillator | 9.74 | 50.00 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.